Analgesics

Anagelisics

Refine your search results by using the drop-down menus below, or choose “Advanced Search This List.”

Search By Category
Sort By
  • Includes Credits

    CE Hours: 1.75

    Description: When a patient has persistent pain after root canal treatment it can be disruptive to a practitioner’s schedule and psyche. The first part of this two-part session will give practitioners a review of practice-based research outcomes on persistent pain, differential diagnosis for persistent pain following root canal treatment, pharmacologic management of persistent pain on the neurobiology of pain. The second part of the session will present cases of patients with persistent post-treatment pain, diagnostic and treatment considerations, and pharmacologic management, with opportunities for audience questions.

    Learning Objectives: 

    • Discuss treatment options for managing persistent pain following endodontic treatment.
    • Discuss pharmacologic management of persistent pain.
    • Discuss how endodontists can work with facial pain practitioners to manage patients with persistent pain.


    Alan S. Law, DDS, PhD

    Dr. Alan Law received his Doctor of Dental Surgery and Certificate in Endodontics from the University of Iowa College of Dentistry, Iowa City, Iowa. He also completed his PhD, “Mechanisms and Modulation of Orofacial Pain”, with the Department of Pharmacology at the University of Iowa. Dr. Law has published over 40 articles in scientific and clinical journals, and has co-authored chapters on The Non-Odontogenic Toothache and Regenerative Endodontics in Pathways of the Pulp, and has lectured at over 300 local, national and international meetings. Dr. Law is a member the American Dental Association, American Association of Endodontics, and Omicron Kappa Upsilon Dental Honor Society, and a Fellow of the American College of Dentists and the International College of Dentists. He is a Past President of the American Association of Endodontists, Past President of the Minnesota Association of Endodontists, and Past President of the American Board of Endodontics. He is in full –time practice in the Twin Cities, and President of The Dental Specialists, a multi-specialty dental practice with over 35 specialists. He is also a Research Professor in the Division of Endodontics at the University of Minnesota.

    Speaker Disclosure

    In accordance with this policy, I declare I have a past or present proprietary or relevant financial relationship or receive gifts in kind (including soft intangible remuneration), consulting position or affiliation, or other personal interest of any nature or kind in any product, service, course and/or company, or in any firm beneficially associated therewith, as indicated: National Dental Practice-Based Research Network and the American Dental Association.

    Karen Baker, BSRPh, MS

    Professor Karen Baker has been on the Dental College faculty at the University of Iowa for over 40 years and occupies a unique role in dental practice and education. She is a clinical pharmacist with a Master’s degree in clinical pharmacology and therapeutics and is focused on patient-specific dental drug therapy. She has given well over 1000 invited programs nationally and internationally and holds memberships in many dental and clinical pharmacology and therapeutics organizations. Her dental education-based pharmacy and drug therapy consultation center is the only one in the United States. She has authored many articles and abstracts and lectures extensively in pre-doctoral and graduate courses at the University of Iowa.

    Speaker Disclosure 

    I declare that I have no proprietary, financial, or other personal interest of any nature or kind in any product, service, course, and/or company, or in any firm beneficially associated therewith, that will be discussed or considered during the proposed presentation.

  • Includes Credits

    CE Hours: 1.25

    Description: When a patient has persistent pain after root canal treatment it can be disruptive to a practitioner’s schedule and psyche. The first part of this two-part session will give practitioners a review of practice-based research outcomes on persistent pain, differential diagnosis for persistent pain following root canal treatment, pharmacologic management of persistent pain on the neurobiology of pain. The second part of the session will present cases of patients with persistent post-treatment pain, diagnostic and treatment considerations, and pharmacologic management, with opportunities for audience questions.

    Learning Objectives: 

    • Discuss the frequency of persistent pain following root canal treatment based upon results of recent practice-based research.
    • Discuss potential predictors of persistent pain following root canal treatment based upon results of recent practice-based research.
    • Discuss a differential diagnosis for persistent pain following root canal treatment


    Alan S. Law, DDS, PhD

    Dr. Alan Law received his Doctor of Dental Surgery and Certificate in Endodontics from the University of Iowa College of Dentistry, Iowa City, Iowa. He also completed his PhD, “Mechanisms and Modulation of Orofacial Pain”, with the Department of Pharmacology at the University of Iowa. Dr. Law has published over 40 articles in scientific and clinical journals, and has co-authored chapters on The Non-Odontogenic Toothache and Regenerative Endodontics in Pathways of the Pulp, and has lectured at over 300 local, national and international meetings. Dr. Law is a member the American Dental Association, American Association of Endodontics, and Omicron Kappa Upsilon Dental Honor Society, and a Fellow of the American College of Dentists and the International College of Dentists. He is a Past President of the American Association of Endodontists, Past President of the Minnesota Association of Endodontists, and Past President of the American Board of Endodontics. He is in full –time practice in the Twin Cities, and President of The Dental Specialists, a multi-specialty dental practice with over 35 specialists. He is also a Research Professor in the Division of Endodontics at the University of Minnesota.

    Speaker Disclosure

    In accordance with this policy, I declare I have a past or present proprietary or relevant financial relationship or receive gifts in kind (including soft intangible remuneration), consulting position or affiliation, or other personal interest of any nature or kind in any product, service, course and/or company, or in any firm beneficially associated therewith, as indicated: National Dental Practice-Based Research Network and the American Dental Association.

    Karen Baker, BSRPh, MS

    Professor Karen Baker has been on the Dental College faculty at the University of Iowa for over 40 years and occupies a unique role in dental practice and education. She is a clinical pharmacist with a Master’s degree in clinical pharmacology and therapeutics and is focused on patient-specific dental drug therapy. She has given well over 1000 invited programs nationally and internationally and holds memberships in many dental and clinical pharmacology and therapeutics organizations. Her dental education-based pharmacy and drug therapy consultation center is the only one in the United States. She has authored many articles and abstracts and lectures extensively in pre-doctoral and graduate courses at the University of Iowa.

    Speaker Disclosure 

    I declare that I have no proprietary, financial, or other personal interest of any nature or kind in any product, service, course, and/or company, or in any firm beneficially associated therewith, that will be discussed or considered during the proposed presentation.

  • Includes Credits

    CE Hours: 1.75

    Description: This presentation will first identify the potential problem in prescribing opioids for dental postsurgical pain and other painful dental conditions. The biochemical and physiological mechanisms behind post-surgical dental pain will be reviewed and a discussion of various double-blind randomized controlled trials on the efficacy of various analgesic agents following the surgical removal of impacted third molar teeth will take place. A discussion of the “drug seeking patient” and the prescription opioid abuse problem will be highlighted. The final portion of this discussion will focus on meta-analysis data for various analgesics in both dental pain and other post-surgical pain models. In other words, “Which analgesics consistently lead the pack and which are consistently dogs.” An updated flexible analgesic schedule which was published in JADA will finalize the program.

    Learning Objectives: 

    • Explain the potential consequences of even short-term exposure to opioids.
    • Compare the analgesic efficacy of NSAIDs to single entity oral opioids and acetaminophen/opioid combination drugs in randomized placebo controlled double-blind oral surgery pain studies.
    • Summarize meta-analysis data of NSAIDs and opioid combination drugs on the numbers needed treat (NNT) to obtain one additional patient with at least 50% maximum pain relief.

    Elliot V. Hersh, D.MD, M.S., Ph.D

    Dr. Elliot V. Hersh is currently a professor of pharmacology/oral surgery at the University of Pennsylvania School of Dental Medicine. He received his D.M.D. degree from New Jersey Dental School UMDNJ in 1981 and his M.S. and Ph.D. degrees from UMDNJ – Graduate School of Biomedical Sciences in 1983 and 1988 respectively. Since arriving at the University of Pennsylvania in 1988, Dr. Hersh has won the Dental School’s Excellence in the Teaching of Basic Science Award 22 different times and was also presented with a University Lindback Award in 1993, the highest teaching honor in the entire university. He has published more than 150 scientific articles, abstracts and book chapters in the areas of dental pharmacology, drug interactions, analgesics and local anesthetics. His scholarly and research contributions in the areas of local anesthesia and pain control were recognized by the International Association of Dental Research in 2007 when he was presented with the Distinguished Scientist Award in Pharmacology, Therapeutics and Toxicology. “While the research accolades are nice, the most important thing I do is sharing this knowledge with my students and other dental professionals."

    Disclosure

    In accordance with this policy, I declare I have a past or present proprietary or relevant financial relationship or receive gifts in kind (including soft intangible remuneration), consulting position or affiliation, or other personal interest of any nature or kind in any product, service, course and/or company, or in any firm beneficially associated therewith, as indicated below: Bayer Pharmaceutical (Grant/Research Support).

  • Includes Credits

    CE Hours: 1.5

    Description: The goal of outpatient regimens for anxious dental patients is often described as 'sedation', a non-specific decrease in consciousness and patient responsiveness which is often accompanied by respiratory depression. The patient perspective suggests that reduction in anxiety and minimal pain during the procedure are more specific outcomes that can be accomplished with drugs that produce negligible CNS depression: benzodiazepines, effective local anesthesia and nitrous oxide. This presentation will describe the scientific evidence to support safe pharmacologic strategies for outpatient procedures without the risks of parenteral drug administration or additive drug combinations that incrementally reduce safety with little benefit to the patient.

    Learning Objectives:  

    • Identify the major variable that contributes to therapeutic efficacy and sedation for outpatient sedation procedures in dental offices
    • Identify the drugs, doses and routes of administration that optimize the balance between safety and therapeutic success
    • Identify the benefits of having an appropriately trained clinician to monitor the patient, administer the anxiolytic agents and manage adverse events independent of the clinician performing the dental procedure

    Raymond Dionne, D.D.S., M.S. Ph.D.

    Dr. Dionne received a DDS from Georgetown University and a PhD from the Medical College of Virginia. He conducted clinical and translational pain research at the National Institute of Dental and Craniofacial Research for 34 years, as well as practiced dentistry part-time in the District of Columbia. He is currently a restless retiree living in Missouri.

    Speaker Disclosure

    In accordance with this policy, I declare I have a past or present proprietary or relevant financial relationship or receive gifts in kind (including soft intangible remuneration), consulting position or affiliation, or other personal interest of any nature or kind in any product, service, course and/or company, or in any firm beneficially associated therewith, as indicated: AIM Targeted Therapeutics: Consultant on preclinical development of an investigational analgesic formulation (Ongoing); Rilento Pharma: consultant for pre-clinical development of investigational analgesic formulation (Ongoing)

  • Includes Credits

    CE Hours: 1.0

    Description: The management of emergencies is an integral part of dental practice as patients may present at any time with an emergency. Pain associated with the dental pulp and/or periapical tissues is the most common emergency. Such endodontic emergencies may occur before, during or after endodontic treatment. Hence, all Dentists and Endodontists must be able to effectively manage endodontic emergencies in order to predictably relieve the patient’s pain, reduce any swelling, and return the tooth to normal function. Such patients may have to be “squeezed in” to an already busy day’s schedule of booked patients so efficient management is also essential. Predictable management is based on the general principles of accurate diagnosis and appropriate treatment, and in some cases post-operative medication. Whilst this sounds simple, there can be complicating factors - such as obtaining adequate local anesthesia to allow pain-free pulp removal from teeth with acute irreversible pulpitis. This presentation will outline the common endodontic emergencies and how to predictably, effectively and efficiently manage them.

    Learning Objectives:  

    • Explain the common endodontic emergencies and when they occur
    • Differentiate between the various endodontic emergencies in order to accurately diagnose each condition
    • Explain appropriate strategies to effectively and predictably manage emergencies in an efficient manner

    Paul V. Abbott, B.D.Sc., M.D.S., FRACDS(Endo)

    Paul Abbott is an Emeritus Professor of Dentistry at The University of Western Australia. He is a Specialist Endodontist. Prior to taking a full-time University position in 2002, he spent 17 years in private specialist endodontic practice and he also held part-time academic positions at The University of Western Australia and the University of Melbourne. He was Dean and Head of the School of Dentistry at The University of Western Australia and Director of the Oral Health Centre of Western Australia from 2003- 2009. He has presented over 1000 lectures and courses in 49 countries. He has published 230 articles in refereed journals, 25 textbook chapters and 47 Newsletter articles. From 2015-2022, he was the Editor-in-Chief of the international journal Dental Traumatology. Prof. Abbott’s main research and clinical interests revolve around dental
    traumatology, tooth resorption, the diagnosis and management of pulp, root canal and peri-radicular conditions, with particular emphasis on pain control and disinfection of the root canal system. Prof. Abbott has received numerous awards for excellence in teaching and service to the dental profession, particularly in education and research. In 2015, the Governor-General of Australia appointed Prof. Abbott as an Officer of the Order of Australia (AO) - one of the highest honours in Australia – “For distinguished service to clinical dentistry, and to higher education, as an academic, researcher and author, to endodontics as a practitioner, and to professional organisations.”

  • Includes Credits

    CE Hours: 1.5

    Description: This course will review the latest studies on pain management from the perspective of treating both acute and persistent post-endodontic pain. We will provide recommendations for suitable drugs, their dosing and rationale using case based scenarios to best manage endodontic patients in pain.

    Learning Objectives: 

    • Describe common mechanisms for acute and persistent post-endodontic pain
    • Describe a strategy for selection of various medications for treating these patients
    • Describe indications, contraindications and potential adverse effects of these medications

    Kenneth Hargreaves, D.D.S., Ph.D.

    Ken Hargreaves received his DDS from Georgetown University, his PhD in physiology from the Uniformed Services University of the Health Sciences in Bethesda, MD, and his certificate in Endodontics from the University of Minnesota. Ken spent 5 years at the Pain Clinic of the NIDCR and 7 years as an associate professor of Endodontics and Pharmacology at the University of Minnesota. He joined the University of Texas Health Science Center at San Antonio in 1997, as professor and Chair of the Department of Endodontics and is cross-appointed as professor in the Departments of Pharmacology, Physiology and Surgery in the Medical School. He maintains a private practice limited to endodontics and is a Diplomate of the American Board of Endodontists. Ken has received an NIH MERIT Award for research, two IADR Distinguished Scientist Awards, the ADA Gold Medal for Research and the Louis I. Grossman Award from the AAE. He has published more than 190 articles and, with Harold Goodis and Frank Tay, co-edited the 2nd edition Seltzer and Bender’s Dental Pulp, and, with Lou Berman, co-edited the 11th edition of Cohen’s Pathways of the Pulp. Ken also serves as editor of the Journal of Endodontics.

    Speaker Disclosure: 

    I declare that I have no proprietary, financial, or other personal interest of any nature or kind in any product, service, course, and/or company, or in any firm beneficially associated therewith, that will be discussed or considered during the proposed presentation

    Nikita Ruparel, D.D.S., M.S., Ph.D.

    Dr. Ruparel is Board certified Endodontist who practices in San Antonio at UT Faculty Endodontics. She is the Director of the Advanced Program in Endodontics at UT San Antonio. She received her certificate in Endodontics in 2013 after receiving her doctoral (PhD) and DDS at The University of Texas Health Science Center at San Antonio. Her practice in Endodontics includes all aspects of modern endodontics. She also lectures at national and international meetings on pain biology and management and regenerative endodontics. She has also been awarded the American Association of Endodontics Educator Fellowship for committing her career to academics. Nikita Ruparel is committed to a long-term career as a clinician-scientist.

    Speaker Disclosure

    I declare that I have no proprietary, financial, or other personal interest of any nature or kind in any product, service, course, and/or company, or in any firm beneficially associated therewith, that will be discussed or considered during the proposed presentation.

  • Includes Credits

    CE Hours: 1.0

    Description: The FDA funded the development of analgesic prescribing deadlines for the dental profession that was conducted by the ADA and the University of Pittsburgh. The process and results of these deliberations will be presented and critiqued in this presentation.

    Learning Objectives: 

    • Attendees will become aware that clinical practice guidelines are limited by the available evidence such that hindsight is not always "20/20"
    • Describe how lasers work and the role of lasers in Radial Apical Cleansing – a new protocol for the management of root canal systems
    • Based on the information presented attendees will be able to manage pain based on the latest national recommendations for safe and efficacious analgesia for acute dental

    Raymond Dionne, D.D.S., M.S. Ph.D.

    Dr. Dionne received a DDS from Georgetown University and a PhD from the Medical College of Virginia. He conducted clinical and translational pain research at the National Institute of Dental and Craniofacial Research for 34 years, as well as practiced dentistry part-time in the District of Columbia. He is currently a restless retiree living in Missouri.

    Speaker Disclosure

    In accordance with this policy, I declare I have a past or present proprietary or relevant financial relationship or receive gifts in kind (including soft intangible remuneration), consulting position or affiliation, or other personal interest of any nature or kind in any product, service, course and/or company, or in any firm beneficially associated therewith, as indicated: AIM Targeted Therapeutics: Consultant on preclinical development of an investigational analgesic formulation (Ongoing); Rilento Pharma: consultant for pre-clinical development of investigational analgesic formulation (Ongoing)

  • Includes Credits

    CE Hours: 2.25

    Description: This presentation will first review the biochemical and physiological mechanisms behind post-surgical dental pain and then discuss various double-blind randomized controlled trials on the efficacy of various analgesic agents following the surgical removal of impacted third molar teeth. A discussion of the “drug seeking patient” and the prescription opioid abuse problem will be highlighted. The final portion of this discussion will focus on meta-analysis data for various analgesics in both dental pain and other post-surgical pain models. “IN OTHER WORDS WHICH ANALGESICS CONSISTENTLY LEAD THE PACK AND WHICH ARE CONSISTENTLY DOGS”. An updated flexible analgesic schedule which was first published in JADA in August 2013 will also be discussed.

    • List various peripheral chemical mediators which contribute to post-surgical dental pain.
    • Compare the short-term side effects profile of NSAIDs versus opioids.
    • Discuss meta-analysis data on the numbers needed to treat (NNT) to obtain one additional patient with at least 50% maximum pain relief beyond the placebo treatment.

    Elliot V. Hersh, D.MD, M.S., Ph.D

    Dr. Elliot V. Hersh is currently a professor of pharmacology/oral surgery at the University of Pennsylvania School of Dental Medicine. He received his D.M.D. degree from New Jersey Dental School UMDNJ in 1981 and his M.S. and Ph.D. degrees from UMDNJ – Graduate School of Biomedical Sciences in 1983 and 1988 respectively. Since arriving at the University of Pennsylvania in 1988, Dr. Hersh has won the Dental School’s Excellence in the Teaching of Basic Science Award 22 different times and was also presented with a University Lindback Award in 1993, the highest teaching honor in the entire university. He has published more than 150 scientific articles, abstracts and book chapters in the areas of dental pharmacology, drug interactions, analgesics and local anesthetics. His scholarly and research contributions in the areas of local anesthesia and pain control were recognized by the International Association of Dental Research in 2007 when he was presented with the Distinguished Scientist Award in Pharmacology, Therapeutics and Toxicology. “While the research accolades are nice, the most important thing I do is sharing this knowledge with my students and other dental professionals."

    Disclosure

    In accordance with this policy, I declare I have a past or present proprietary or relevant financial relationship or receive gifts in kind (including soft intangible remuneration), consulting position or affiliation, or other personal interest of any nature or kind in any product, service, course and/or company, or in any firm beneficially associated therewith, as indicated below: Bayer Pharmaceutical (Grant/Research Support).

    Elliott V. Hersh, D.MD, M.S., Ph.D
    In accordance with this policy, I declare I have a past or present proprietary or relevant financial relationship or receive gifts in kind (including soft intangible remuneration), consulting position or affiliation, or other personal interest of any nature or kind in any product, service, course and/or company, or in any firm beneficially associated therewith, as indicated: AAI Pharmaceutical () : Grant/Research Support; Bayer Pharmaceutical (Self) : Consultant (Status: Terminated --- March 1, 2020); Cetylite Inc () : Grant/Resear